Breaking news
The NHS will start using an arthritis drug to treat hospitalised Covid patients after a breakthrough study found it cuts the risk of dying. Tocilizumab can reduce swelling inside the organs and, when combined with steroid dexamethasone slashes the odds of death by a third. Oxford University scientists behind the RECOVERY trial found the drug … Read more
An anti-inflammatory drug used to treat arthritis, which has been hailed by Boris Johnson as a ‘life-saving’ Covid-19 treatment, may be ineffective — and could even increase the patient’s risk of dying — according to a new study. The latest research, published in the BMJ, found 11 of 65 people (17 per cent) treated with tocilizumab … Read more
Boris Johnson tonight hailed two ‘life-saving’ arthritis drugs after a major British trial revealed they cut the risk of death in critically-ill Covid patients by nearly a quarter. The PM — who stumbled several times as he tried to pronounce them — said the anti-inflammatory drugs tocilizumab and sarilumab would be made available through the NHS with immediate … Read more
Coronavirus patients in ICU will now receive a now course of treatment on the NHS after a major trial found a single dose of common arthritis drugs reduces the risk of dying from Covid-19 by nearly a quarter. Anti-inflammatory drugs tocilizumab and sarilumab were part of the REMAP-CAP investigation which involved 3,900 people with severe Covid-19 … Read more
A mother who was in a coma and given three days to live after contracting coronavirus has made a miraculous recovery with help from an experimental drug. The family of Claire Haythorne, 45, from Hillsborough, Sheffield, said they had been through the ‘hardest two months’ of their lives. She contracted the virus at the start … Read more
FDA gives emergency approval to Eli Lilly’s arthritis drug paired with remdesivir for treating hospitalized coronavirus patients – after WHO warns NOT to use the antiviral FDA issued emergency use authorization for the use of Eli Lilly’s rheumatoid arthritis drug baricitinib in combination with remdesiver to treat COVID-19 The approval, made Thursday, comes as World … Read more
The arthritis drug tocilizumab can help critically-ill Covid-19 patients recover, a large British trial has found. Patients given the drug in a clinical trial led by Imperial College London were found to be 87 per cent more likely to see their symptoms improve than patients not given the drug. But because the study is ongoing, … Read more
‘I’d been feeling stressed and had not been sleeping much,’ recalls Dasha, who was 19 at the time. ‘I thought it was conjunctivitis’ Student Dasha Karzunina assumed at first that the red, painful eye she had developed while revising for her university exams was a simple infection. ‘I’d been feeling stressed and had not been … Read more
Arthritis drug ‘cuts elderly Covid-19 deaths by two-thirds’, say researchers – raising hopes that it will save the most vulnerable Daily drug reduces deaths by 71 per cent in those with moderate or severe illness Drug baricitinib, marketed as Olumiant, has only been available for three years Medics hope the arthritis drug could help save most … Read more
NHS patients with rheumatoid arthritis are to benefit from a breakthrough drug that eases the agonising pain in joints. The condition affects 400,000 Britons – many of them young adults – who can be left wheelchair-bound due to the pain and energy-sapping exhaustion it causes. Current treatments are able to soothe pain and dampen inflammation … Read more